PD168393
≥98%
- Product Code: 77725
CAS:
194423-15-9
| Molecular Weight: | 369.22 g./mol | Molecular Formula: | C₁₇H₁₃BrN₄O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD02179207 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
PD168393 is primarily used in research settings as a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. It is particularly valuable in studies aimed at understanding the role of EGFR signaling in cellular processes, such as proliferation, differentiation, and survival. Researchers utilize PD168393 to investigate the mechanisms of cancer development and progression, as EGFR is often overactive in various types of tumors. Additionally, it helps in exploring potential therapeutic strategies by blocking EGFR activity, which can inhibit tumor growth. This compound is also employed in pharmacological studies to assess the efficacy and specificity of EGFR inhibitors in preclinical models.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | white to beige powder |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿10,160.00 |
+
-
|
| 0.050 | 10-20 days | ฿29,990.00 |
+
-
|
PD168393
PD168393 is primarily used in research settings as a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. It is particularly valuable in studies aimed at understanding the role of EGFR signaling in cellular processes, such as proliferation, differentiation, and survival. Researchers utilize PD168393 to investigate the mechanisms of cancer development and progression, as EGFR is often overactive in various types of tumors. Additionally, it helps in exploring potential therapeutic strategies by blocking EGFR activity, which can inhibit tumor growth. This compound is also employed in pharmacological studies to assess the efficacy and specificity of EGFR inhibitors in preclinical models.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :